Geode Capital Management LLC Cuts Stock Holdings in Humana Inc. (NYSE:HUM)

Geode Capital Management LLC cut its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 0.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,820,052 shares of the insurance provider's stock after selling 2,851 shares during the period. Geode Capital Management LLC owned 2.34% of Humana worth $890,142,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of HUM. Creative Financial Designs Inc. ADV increased its stake in Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock valued at $27,000 after purchasing an additional 61 shares during the period. CarsonAllaria Wealth Management Ltd. grew its holdings in shares of Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider's stock worth $28,000 after buying an additional 39 shares during the last quarter. Atwood & Palmer Inc. acquired a new position in Humana in the 3rd quarter valued at about $29,000. Ashton Thomas Securities LLC purchased a new stake in Humana during the 3rd quarter valued at approximately $31,000. Finally, Your Advocates Ltd. LLP lifted its position in Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock worth $32,000 after acquiring an additional 45 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Price Performance

Shares of HUM traded down $5.42 during trading hours on Thursday, reaching $272.78. 1,640,433 shares of the company traded hands, compared to its average volume of 1,843,532. The stock has a market capitalization of $32.85 billion, a PE ratio of 24.63, a price-to-earnings-growth ratio of 2.18 and a beta of 0.53. The stock has a fifty day simple moving average of $272.83 and a 200 day simple moving average of $325.59. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $488.89. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analysts' expectations of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, research analysts predict that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.30%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana's dividend payout ratio is currently 31.36%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on HUM shares. KeyCorp initiated coverage on Humana in a report on Friday, October 11th. They issued a "sector weight" rating on the stock. Stephens restated an "equal weight" rating and set a $250.00 price objective on shares of Humana in a research report on Wednesday, October 9th. Oppenheimer reduced their target price on shares of Humana from $400.00 to $280.00 and set an "outperform" rating for the company in a research note on Thursday, October 3rd. Piper Sandler lowered shares of Humana from an "overweight" rating to a "neutral" rating and dropped their price target for the stock from $392.00 to $274.00 in a research note on Thursday, October 3rd. Finally, JPMorgan Chase & Co. raised their price objective on shares of Humana from $332.00 to $396.00 and gave the company a "neutral" rating in a research report on Wednesday, August 21st. Twenty research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, Humana currently has a consensus rating of "Hold" and an average target price of $315.86.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.